As the potential of molecular glue technology becomes increasingly apparent, pharmaceutical companies are beginning to invest more heavily in this area.

The Fab fragment, also known as the antigen-binding fragment, is the region of an antibody that can bind with antigens.

A Polyclonal antibody (PAb) is a mixture of antibodies produced by different B cells in the body against the same antigen.

A Contrast agent, also known as a contrast medium, is a specific substance that is introduced into the human body for the purpose of medical imaging – it is used to alter the contrast of images of parts of the body.

Challenging the pathogenicity of bacteria through Bacteriophage therapy could lead the way to improved antibiotic strategies.

Mesenchymal stem cells (MSCs) have broad therapeutic potential for treating inflammation and degenerative diseases.

Molecular glue can enhance and stabilize protein interactions; it can also repair protein interactions that have been weakened due to mutations.

Long noncoding RNAs (LncRNA) are a type of transcript that is over 200nt in length and does not code for proteins.

Circular RNA (circRNA) is a type of single-stranded RNA with a closed loop structure, initially found in HDV and plant viruses.

Proteolysis Targeting Chimeras (PROTACs) technology is a new protein degradation strategy that has emerged in recent years.

Oncolytic virus (OVs) refers to a generic name for viruses that naturally exist or are genetically edited to selectively kill tumor cells.

Recombinant protein refers to the protein obtained using recombinant DNA or RNA technology.